What is Medicus Sciences Acquisition Corp.'s annual revenue?

Medicus Sciences Acquisition Corp. (MSAC) reported annual revenue of $0 in its most recent fiscal year.

What is Medicus Sciences Acquisition Corp.'s net profit?

Medicus Sciences Acquisition Corp. (MSAC) reported net profit of $2.0M in its most recent fiscal year.

What is MSAC EV/EBITDA?

Medicus Sciences Acquisition Corp.'s enterprise value to EBITDA (EV/EBITDA) ratio is 2.33.

NASDAQ · Financial Statements

Medicus Sciences Acquisition Corp. (MSAC) Financial Statements

$10.17 NASDAQ: MSAC

Medicus Sciences Acquisition Corp. most recently reported annual revenue of $0, net profit of $2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2020	2021
Revenue	—	$0
Operating Profit	—	$-1.0M
Net Profit	—	$2.0M
EPS	—	$0.18
Op Margin	—	—

Balance Sheet (USD)

Metric	2020	2021
Total Assets	$0	$94.0M
Total Liabilities	$0	$8.0M
Cash	$0	$1.0M
Borrowings	$0	$0

Cash Flow (USD)

Metric	2020	2021
Operating Cash Flow	—	$-1.0M
Investing Cash Flow	—	$-92.0M
Financing Cash Flow	—	$94.0M
Net Cash Flow	—	$1.0M
Free Cash Flow	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.20
EV / EBITDA	2.33
FCF Yield	—
Quick Ratio	49.37
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Financial Services Stocks Low P/E Financial Services Stocks High Net Margin Financial Services Stocks Dividend Financial Services Stocks Low Debt Financial Services Stocks Nasdaq High ROE Stocks All stock screens

MSAC Overview MSAC Dividend Run Stock Screener